5 hours ago
1
Dianthus Therapeutics (NASDAQ:DNTH) has priced its recently announced and upsized public offering, raising approximately $251 million in gross proceeds, by selling 6.49 million shares of common stock at $33.00 per share and, to some investors, pre-funded warrants for up to 1.11 million shares at $32.999 each.
Related
Rocket Companies trades higher as BofA upgrades on lower rat...
8 minutes ago
0
startup layoffs india delhi man posted on reddit after being...
9 minutes ago
0
Chewy beats Q2 sales expectations, raises FY25 guidance
11 minutes ago
0
August producer inflation unexpectedly declines on both head...
15 minutes ago
0
Wells Fargo stays bullish, betting AI will power S&P 500 to ...
18 minutes ago
0
I’ve been researching generative AI for years, and I’m tired...
19 minutes ago
0
Big companies are already dialing back on error-prone AI and...
19 minutes ago
0
Equinor mulls over renewable asset combination with Danish w...
19 minutes ago
0
Lucid Diagnostics dips after pricing $25M stock offering
19 minutes ago
0
White House mulls restrictions on medicines invented in Chin...
23 minutes ago
0
Sprott launches Active Metals & Miners ETF
26 minutes ago
0
Rubis GAAP EPS of €1.58, revenue of €3.28B; reaffirms FY25 o...
26 minutes ago
0
Joby, Uber to bring Blade’s air mobility services to Uber ap...
27 minutes ago
0
Seaport Entertainment appoints Matt Partridge CEO
32 minutes ago
0
PsiQuantum hits $7B valuation, partners with Nvidia to boost...
36 minutes ago
0
K. Hovnanian Enterprises announces new senior notes offering...
37 minutes ago
0
France’s ‘Block Everything’ protests disrupt cities, deepen ...
38 minutes ago
0
Potbelly to be acquired by RaceTrac in $566M transaction
40 minutes ago
0
GE HealthCare to acquire icometrix
41 minutes ago
0
Daktronics GAAP EPS of $0.33 beats by $0.12, revenue of $218...
45 minutes ago
0
Popular
فیلم/ پارلمان نپال به تصرف معترضان درآمد
1 day ago
3
English (US) · © FBT Company 2025. All rights are reserved